Unknown

Dataset Information

0

Effect of Prophylactic Fentanyl Buccal Tablet on Episodic Exertional Dyspnea: A Pilot Double-Blind Randomized Controlled Trial.


ABSTRACT: CONTEXT:Episodic dyspnea is one of the most common, debilitating, and difficult-to-treat symptoms. OBJECTIVE:We conducted a pilot study to examine the effect of prophylactic fentanyl buccal tablet (FBT) on exercise-induced dyspnea. METHODS:In this parallel, double-blind randomized placebo-controlled trial, opioid-tolerant patients were asked to complete a six-minute walk test (6MWT) at baseline and then a second 6MWT 30 minutes after a single dose of FBT (equivalent to 20-50% of their total opioid dose) or matching placebo. We compared dyspnea Numeric Rating Scale (NRS, 0-10, primary outcome), walk distance, vital signs, neurocognitive function, and adverse events between the two 6MWTs. RESULTS:Among 22 patients enrolled, 20 (91%) completed the study. FBT was associated with a significant within-arm reduction in dyspnea NRS between 0 and six minutes (mean change -2.4, 95% CI -3.5, -1.3) and respiratory rate (mean change -2.6, 95% CI -4.7, -0.4). Placebo was also associated with a nonstatistically significant decrease in dyspnea (mean change -1.1). Between-arm comparison of dyspnea scores in the second 6MWT favored FBT, albeit not statistically significant (estimate -0.25, P = 0.068). Global impression revealed more patients in the FBT group than placebo group reporting their dyspnea was at least "somewhat better" in the second 6MWT (4 of 9 vs. 0 of 11, P = 0.03). The other secondary outcomes did not differ significantly between arms. CONCLUSIONS:This study supports that prophylactic FBT was associated with a reduction of exertional dyspnea and was well tolerated. Our findings support the need for larger trials to confirm the therapeutic potential of rapid-onset opioids.

SUBMITTER: Hui D 

PROVIDER: S-EPMC5705410 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effect of Prophylactic Fentanyl Buccal Tablet on Episodic Exertional Dyspnea: A Pilot Double-Blind Randomized Controlled Trial.

Hui David D   Kilgore Kelly K   Frisbee-Hume Susan S   Park Minjeong M   Liu Diane D   Balachandran Diwakar D DD   Bruera Eduardo E  

Journal of pain and symptom management 20170810 6


<h4>Context</h4>Episodic dyspnea is one of the most common, debilitating, and difficult-to-treat symptoms.<h4>Objective</h4>We conducted a pilot study to examine the effect of prophylactic fentanyl buccal tablet (FBT) on exercise-induced dyspnea.<h4>Methods</h4>In this parallel, double-blind randomized placebo-controlled trial, opioid-tolerant patients were asked to complete a six-minute walk test (6MWT) at baseline and then a second 6MWT 30 minutes after a single dose of FBT (equivalent to 20-5  ...[more]

Similar Datasets

| S-EPMC5075501 | biostudies-literature
| S-EPMC3808512 | biostudies-literature
| S-EPMC4958556 | biostudies-literature
| S-EPMC8342581 | biostudies-literature
| S-EPMC8431258 | biostudies-literature
| S-EPMC3951298 | biostudies-literature
| S-EPMC8585675 | biostudies-literature
| S-EPMC2894750 | biostudies-literature
| S-EPMC6997562 | biostudies-literature
| S-EPMC4451291 | biostudies-literature